Other grades of this product :
| Lusutrombopag Basic information |
| Product Name: | Lusutrombopag | | Synonyms: | Lusutrombopag S-888711;(E)-3-[2,6-dichloro-4-[4-[3-[(S)-1-hexyloxyethyl]-2-methoxyphenyl]thiazol-2-ylcarbamoyl]phenyl]-2-methylacrylic acid;S 888711;S888711;S888711;S 888711;2-Propenoic acid, 3-[2,6-dichloro-4-[[[4-[3-[(1S)-1-(hexyloxy)ethyl]-2-methoxyphenyl]-2-thiazolyl]amino]carbonyl]phenyl]-2-methyl-, (2E)- | | CAS: | 1110766-97-6 | | MF: | C29H32Cl2N2O5S | | MW: | 591.55 | | EINECS: | | Product Categories: | API | | Mol File: | 1110766-97-6.mol |
| Lusutrombopag Chemical Properties |
| density | 1.299±0.06 g/cm3(Predicted) | | pka | 4.33±0.21(Predicted) |
| Lusutrombopag Usage And Synthesis |
| Uses | Lusutrombopag is a newly discovered thrombopoietin receptor agonist used in the treatment of patients with chronic ITP. |
| Lusutrombopag Preparation Products And Raw materials |
|
日本语
한국어
Français
Deutsch
España
Türkiye